What Happened On Thursday To Make MacroGenics (MGNX) Stock Jump After-Hours?
Shares of MacroGenics Inc. (NASDAQ: MGNX) increased 6.25% to $6.97 on Thursday after the company reached a critical regulatory clearance milestone. What does this achievement entail for MGNX? Teplizumab, an anti-CD3 monoclonal antibody that was previously created by MacroGenics, received approval of the Biologics License Application (BLA) from the U.S. Food and Drug Administration, according […]
